Home

MECTA Corporation does not provide medical advice, nor do we sell our products to anyone but licensed clinicians and hospitals. Please contact your local mental health provider, Veteran’s hospital, or University hospital for information about electroconvulsive therapy (ECT). Contact 911 in case of a mental health emergency. MECTA does not sell to nor provide service to third parties.


Sign up to become a MECTA Service Subscriber
	Sign up to expedite Clinical Accessories orders
Contact Us
Request for Quotation
Request for Service Quote
 
     
     
Home
 
Redefining Electroconvulsive Therapy
 

MECTA Corporation has defined the highest standard of excellence in the field of ECT neuromodulation devices through evidence-based research since its inception. Furthermore, MECTA's four forms of ECT innovations span over forty years. A breakthrough by Dr. Paul Blachley with MECTA ECT research in 1973 at Oregon Health Sciences University produced the first and only, monitored (EEG/ECG), brief pulse ECT devices - MECTA C and D. Subsequent research at Columbia University was implemented into the third generation MECTA SR and JR digital devices which were introduced in 1985, and they utilized the first RUL ECT, multiple dosing schemes and titration.47

In 1998 controlled research from Duke University and Columbia University was integrated into the current MECTA spECTrum 5000* and 4000™* devices, the first and only EEG Data Analysis** feature,39 and the spECTrum ULTRABRIEF©2003 ECT 51 which dramatically minimizes cognitive effects. In 2011, Optimized ECT©2011 was introduced based on further research from Columbia University, ensuring robust efficacy and lower amnestic effects, thus optimizing the treatment further.25,54 MECTA also created the Optimized Titration Tables based on age, sex and gender for further optimization.13 This level of innovation from MECTA has continued to lead the field of ECT!

MECTA ECT has advanced the highest standard of excellence for over forty years. ECT continues to be the only neuromodulation modality providing up to an 80% response rate. 42 We are proud that MECTA's innovative device designs, which have been utilized worldwide in peer reviewed, randomized, double-blind studies, have resulted in optimized patient outcomes through four generations of ECT devices.

 
 
Design All MECTA devices include extensive redundant hardware and software testing to verify that they are operating correctly. The safety of these devices is unparalleled, and as such these devices are an advance that will impact the safety and effectiveness of the ECT treatment.
* U.S. Patent #5,755,744 - U.S. Patent #6,014,587 - U.K. Patent #GB 2 307 413 B
** Duke U.K. Patent #2 304 196 B - U.S. Patent #5,626,627
Quality and Safety Standards MECTA's manufacturing and service operations are regulated under the international ISO 9001 Quality Standard so that MECTA customers can be assured of product safety and quality. MECTA has extensive regulatory agency approvals worldwide: U.S. (UL); Canada (CSA (cUL), Health Canada-8 Approvals, #1537, #62578, #62576); European Union, TUV (EN ISO 13485:2003+AC 2007; CMDCAS ISO 13485:2003, EC 93/42/EEC Annex II, Article 3); EN ISO 9001:2008; Korea (KFDA); Australia (TGA).
technical diagnostics Environment MECTA has always recognized the need to be responsible stewards of the environment. Reduction of manufacturing waste and emissions, responsible operations resources management, and no-charge device recycling, are all integral parts of MECTA's environmental policy. We are voluntarily committed to achieving 100% RoHS (lead-free) compliance.
Quality Policy It is the policy of MECTA to design, fabricate, market, distribute, and service its ECT equipment with consistently high quality so that MECTA will continue in its position of leadership in the industry. All of our products will meet all applicable laws and regulations. MECTA's emphasis on quality involves all personnel. Our goal is satisfied customers. MECTA continually improves its Quality Management System to meet these objectives.
*patent allowed
     
©2014 MECTA Corporation. All Rights Reserved